Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling

Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling

Jiying Liu,1– 3 Guangyao Fang,2,4 Cong Lan,2 Chenming Qiu,5 Li Yao,2 Qian Zhang,2 Jingtang Hu,2 Yaolei Zhang,6 Yongjian Yang,1,2 Yan Zhang1,2 1Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 2Department of Cardio...

Full description

Bibliographic Details
Main Authors:	Liu J, Fang G, Lan C, Qiu C, Yao L, Zhang Q, Hu J, Zhang Y, Yang Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-03-01
Series:	Drug Design, Development and Therapy
Subjects:	forsythoside b pulmonary arterial hypertension nf-κb signaling pathway pulmonary vascular remodeling pulmonary artery smooth muscle cell
Online Access:	https://www.dovepress.com/forsythoside-b-mitigates-monocrotaline-induced-pulmonary-arterial-hype-peer-reviewed-fulltext-article-DDDT

Similar Items

Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-κB signaling in Alzheimer’s disease
by: Fan’ge Kong, et al.
Published: (2020-10-01)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
by: Lin Huang, et al.
Published: (2022-06-01)

Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition
by: Rui-Xing Wang, et al.
Published: (2020-01-01)

Chronic intermittent hypobaric hypoxia attenuates monocrotaline-induced pulmonary arterial hypertension via modulating inflammation and suppressing NF-κB /p38 pathway
by: Lei Gao, et al.
Published: (2018-03-01)

Forsythoside A inhibits apoptosis and autophagy induced by infectious bronchitis virus through regulation of the PI3K/Akt/NF-κB pathway
by: Jun Xu, et al.
Published: (2023-12-01)

Over-expression of nuclear factor-κB family genes and inflammatory molecules is related to chronic obstructive pulmonary disease
by: Zhou L, et al.
Published: (2018-07-01)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Xiaowei Nie, et al.
Published: (2021-11-01)

CYLD expression in dendritic cells involved in the immunoregulation of pulmonary adenocarcinoma via NF-κB pathway
by: Qinghua Yu, et al.
Published: (2020-01-01)

Diabetes Mellitus Promotes Atrial Structural Remodeling and PARP-1/Ikkα/NF-κB Pathway Activation in Mice
by: Meng T, et al.
Published: (2021-05-01)

NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
by: Megha Talati, et al.
Published: (2014-05-01)

Forsythoside A Modulates Zymosan-Induced Peritonitis in Mice
by: Xiao-Tian Zhang, et al.
Published: (2018-03-01)

Forsythoside B ameliorates diabetic cognitive dysfunction by inhibiting hippocampal neuroinflammation and reducing synaptic dysfunction in ovariectomized mice
by: Xinyu Nan, et al.
Published: (2022-10-01)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018-09-01)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
by: Lei Yang, et al.
Published: (2023-02-01)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
by: Rubin Tan, et al.
Published: (2022-11-01)

Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway
by: Xiao-he Li, et al.
Published: (2018-06-01)

Cigarette smoke-associated inflammation impairs bone remodeling through NFκB activation
by: Yi Lu, et al.
Published: (2021-04-01)

The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways
by: Chaoyi Ye, et al.
Published: (2022-03-01)

Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation
by: Ratoe Suraya, et al.
Published: (2022-06-01)

RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension
by: Lu G, et al.
Published: (2023-10-01)

TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
by: Shi Haixia, et al.
Published: (2023-07-01)

Anti-inflammatory effects of guggulsterone on murine macrophage by inhibiting LPS-induced inflammatory cytokines in NF-κB signaling pathway
by: Zhang JH, et al.
Published: (2016-06-01)

Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
by: Giridharan S, et al.
Published: (2018-10-01)

Cigarette smoke extract stimulates human pulmonary artery smooth muscle cell proliferation: Role of inflammation and oxidative stress
by: Juan Wang, et al.
Published: (2022-06-01)

Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension
by: Wenrui Ma, et al.
Published: (2021-12-01)

Effect of overexpression of microRNA-124 on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Zhu Jian, Chen Tiantian, Liu Zhiyong, Zheng Changlong
Published: (2023-08-01)

Expression of plasma nuclear factor-kappa B cells (NF-κB) and Inhibitory subunit kappa B alpha (IκB-α) in HIV-associated pre-eclampsia
by: Bambanani Zozo, et al.
Published: (2021-01-01)

Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects
by: Ahmad Beik, et al.
Published: (2021-04-01)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
by: Yi Tang, et al.
Published: (2022-04-01)

Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway
by: Suiqing Huang, et al.
Published: (2020-05-01)

Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review
by: Lidan Cui, et al.
Published: (2022-07-01)

Protein Kinase C δ (PKCδ) Attenuates Bleomycin Induced Pulmonary Fibrosis via Inhibiting NF-κB Signaling Pathway
by: Jun Wang, et al.
Published: (2020-04-01)

Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis
by: Cao Q, et al.
Published: (2023-03-01)

HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape
by: Sandra Medrano-Garcia, et al.
Published: (2022-08-01)

The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Ting Wang, et al.
Published: (2022-02-01)

Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation
by: Guangrui Chen, et al.
Published: (2023-01-01)

Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
by: Yusheng Cheng, et al.
Published: (2018-08-01)

Comparison of the Potency of Pterostilbene with NF-κB Inhibitors in Platelet Activation: Mutual Activation by Akt-NF-κB Signaling in Human Platelets
by: Chih-Wei Hsia, et al.
Published: (2021-07-01)

Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension
by: Jingjing Zhou, et al.
Published: (2022-08-01)

Schisandrin B ameliorated chondrocytes inflammation and osteoarthritis via suppression of NF-κB and MAPK signal pathways
by: Ran J, et al.
Published: (2018-05-01)